Recommendations Updated on Diagnosis, Management of Premature/Primary Ovarian Insufficiency
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 16, 2024 -- In an evidence-based guideline issued by the Centre for Research Excellence in Women's Health in Reproductive Life and published online Dec. 8 in Climacteric, updated recommendations are presented for the diagnosis and management of premature/primary ovarian insufficiency (POI).
Nick Panay, M.D., from Queen Charlotte's and Chelsea Hospital at Imperial College London, and colleagues developed guidelines relating to diagnosis and management of POI based on evidence collected from literature searches and assessment. In general, the recommendations were informed by women with lived experience of POI.
The authors note that the prevalence of POI is 3.5 percent, which is higher than previously thought. The updated guidelines included 145 recommendations. The list of clinical questions addressed in this guideline was expanded, including in relation to the role of anti-Müllerian hormone (AMH) in the diagnosis of POI and fertility preservation. The topic of complementary treatments was extended, focusing on nonhormone treatments and lifestyle management. Significant changes from the previous guideline include the recommendation that only follicle stimulating hormone (FSH) >25 IU is required for POI diagnosis and guidance that AMH testing, repeat FSH measurement, and/or AMH may be necessary in cases of diagnostic uncertainty. Recommendations relating to genetic testing, estrogen doses and regimens, use of the combined oral contraceptive, and testosterone therapy were also updated.
"The guideline group concluded that there is still an urgent need for more research on the most appropriate diagnostic and treatment options, but also to further elaborate the impact of estrogen deficiency on the health and life expectancy of the women diagnosed with POI," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Advanced Biological Age Linked to Increased Risk for Incident Dementia
FRIDAY, May 2, 2025 -- Advanced biological age (BA) may be a risk factor for incident dementia, according to a study published online April 30 in Neurology. Yacong Bo, Ph.D...
Exposure to Smoke Pollution Ups Risk for Hospitalization for Respiratory Disease
FRIDAY, May 2, 2025 -- For older adults in the Western United States, exposure to high levels of smoke pollution is associated with an increase in hospitalizations for respiratory...
Exercise Helps Reduce Side Effects From Cancer Treatment
THURSDAY, May 1, 2025 -- Exercise mitigates adverse outcomes associated with cancer and its treatments, according to a review published online April 29 in the British Journal...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.